SSA
ALBO

Schonfeld Strategic Advisors’s Albireo Pharma Inc ALBO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,393
Closed -$397K – 2948
2022
Q4 		$397K Buy
+18,393
New +$389K ﹤0.01% 1661

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Schonfeld Strategic Advisors's ALBO Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 18,393 shares — an estimated $397K sold.

Schonfeld Strategic Advisors first reported a position in ALBO in Q4 2022 and held it in 1 quarter. The position peaked at $397K in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Schonfeld Strategic Advisors reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 18,393 Albireo Pharma Inc shares in Q1 2023, an estimated $397K.
  • Schonfeld Strategic Advisors first reported a position in Albireo Pharma Inc in Q4 2022 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Albireo Pharma Inc position peaked at $397K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.